KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Long-Term Investments (2017 - 2022)

Guardant Health's Long-Term Investments history spans 6 years, with the latest figure at $156.7 million for Q3 2022.

  • For Q3 2022, Long-Term Investments fell 37.36% year-over-year to $156.7 million; the TTM value through Sep 2022 reached $156.7 million, down 37.36%, while the annual FY2021 figure was $698.0 million, 183.07% up from the prior year.
  • Long-Term Investments for Q3 2022 was $156.7 million at Guardant Health, down from $382.6 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $698.0 million in Q4 2021 and bottomed at $3.0 million in Q3 2018.
  • The 5-year median for Long-Term Investments is $242.4 million (2020), against an average of $235.6 million.
  • The largest annual shift saw Long-Term Investments surged 10113.43% in 2019 before it plummeted 83.02% in 2020.
  • A 5-year view of Long-Term Investments shows it stood at $77.6 million in 2018, then skyrocketed by 246.54% to $268.8 million in 2019, then dropped by 8.25% to $246.6 million in 2020, then surged by 183.07% to $698.0 million in 2021, then tumbled by 77.55% to $156.7 million in 2022.
  • Per Business Quant, the three most recent readings for GH's Long-Term Investments are $156.7 million (Q3 2022), $382.6 million (Q2 2022), and $588.5 million (Q1 2022).